Research map: Complete metabolic response to combined BRAF/MEK inhibition (dabrafenib-trametinib) in BRAF V600E-mutated metastatic parotid adenocarcinoma: A case report

Back to the article

Papers in this map

  1. Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial · Vivek Subbiah · 2023 · 338 citations · Cited by this paper
  2. HER3 and HPV in head and neck squamous cell carcinoma: Potential implications of induction chemotherapy on tumor immune microenvironment · 2026 · Related
  3. Dabrafenib and Trametinib in Patients With Tumors With BRAF V600E Mutations: Results of the NCI-MATCH Trial Subprotocol H · April K.S. Salama · 2020 · 306 citations · Cited by this paper
  4. Value of alpha smooth muscle actin (αSMA) and inducible nitric oxide synthase (iNOS) in oral squamous cell carcinoma (OSCC): An immunohistochemical approach to tumor stroma categorization and clinicopathological parameters · 2025 · Related
  5. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer · Martin G. Dalin · 2016 · 218 citations · Cited by this paper
  6. Hypofractionated adjuvant radiotherapy in cutaneous squamous cell and basal cell carcinoma of the head and neck: 50(Gy) in 20 study · 2025 · Related
  7. Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up · C. van Herpen · 2022 · 210 citations · Cited by this paper
  8. Genetic variants in immune mediators as potential molecular biomarkers for oral cancer evaluation: Insights from a systematic revaluation by computational analyses and Bayesian approaches · 2025 · Related
  9. Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study · Razelle Kurzrock · 2020 · 134 citations · Cited by this paper
  10. Utilization of ChatGPT as a reliable aide for differential diagnosis of histopathology in head and neck surgery · 2025 · Related
  11. Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial · Tatsunori Shimoi · 2024 · 34 citations · Cited by this paper
  12. Compromised cervical lymphatic drainage following lymphadenectomy and radiation: an overview of head and neck lymphedema and its emerging pathophysiological implications · 2026 · Related
  13. First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition · Victor T. G. Lin · 2018 · 29 citations · Cited by this paper
  14. Oral care practices and oral mucositis in adult cancer patients receiving chemotherapy, or radiation therapy, or both in a private tertiary care hospital, Karachi, Pakistan · 2026 · Related
  15. Advances in Targeted and Systemic Therapy for Salivary Gland Carcinomas: Current Options and Future Directions · Sushanth Sreenivasan · 2025 · 13 citations · Cited by this paper
  16. Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy · 2025 · Related
  17. Cystadenocarcinoma of the parotid: case report of a BRAF inhibitor treatment · Sabrina Boyrie · 2013 · 9 citations · Cited by this paper
  18. Treatment of recurrent oral carcinoma cuniculatum with immune checkpoint blockade: A case report and literature review · 2025 · Related
  19. Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort · Maximilian Linxweiler · 2024 · 4 citations · Cited by this paper
  20. Transforming malignant salivary gland tumor (MSGTs) treatment with AlphaFold: A promising approach · 2025 · Related
  21. Role of Ancillary Techniques in the Differential Diagnosis of Salivary Gland Carcinomas · António Paiva‐Correia · 2025 · 4 citations · Cited by this paper
  22. Case reports of BRAF V600E-mutated tumors effectively treated using the agnostic approach · Natalya V. Prokudina · 2024 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)